Drawing for XINTELA

USPTO serial 79419826

XINTELA

Reviewed by CopyMark Law Group

Reg. 8428309Status 700Registered
Filing date
Status date
Registration date
Sep 15, 2026
Examiner
KUHN, RIO NICE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with XINTELA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Julie A. Greenberg

Julie A. Greenberg Reising Ethington P.C.755 W. Big Beaver Rd, Suite 1850Troy, MI 48084United States

Goods and services

ClassDescriptionStatusFirst use
001Stem cells for research and scientific purposes; antibodies for research and industrial purposes; DNA and RNA for scientific and industrial purposes; proteins for use within science; kit consisting of stem cells, antibodies and proteins for scientific and industrial purposesACTIVE—
005Stem cells for medical and veterinary purposes; DNA and RNA for medical and veterinary purposes; surgical implants comprised of living tissues, namely, stem cells grown from stem cells; antibodies for medical purposes; biological preparations for the treatment of malignant tumors, biological preparations for use as marker or target of all kinds of cells for therapeutic or diagnostic use and for use as marker or target in different physiological or therapeutic methods for therapeutic or diagnostic use; kit consisting of stem cells, antibodies and proteins for medical and veterinary purposes; all of the foregoing excluding pharmaceutical preparations for use in the treatment and/or management of sleep disordersACTIVE—
042Scientific research services in the fields of stem cell therapy and targeted cancer therapy; laboratory research services in the field of medicine, chemistry, stem cells, DNA, RNA, antibodies and proteins; quality control for othersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 15, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 15, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 3, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 19, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 19, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 28, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 28, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 22, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 27, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 24, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 24, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 24, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 21, 2026RNWLINTERNATIONAL REGISTRATION RENEWED—
Mar 19, 2026RFNTREFUSAL PROCESSED BY IB—
Feb 24, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 24, 2026RFRRREFUSAL PROCESSED BY MPU—
Jan 28, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 27, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 24, 2026DOCKASSIGNED TO EXAMINER—
Jan 23, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 23, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 25, 2025LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Mar 20, 2025SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance